ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Women’s health"

  • Abstract Number: 1767 • ACR Convergence 2020

    Maternal Peripartum Outcomes Are Similar to the General Population in Rheumatoid Arthritis Pregnancies

    Sarah Tarplin1, Alex Camai1 and April Barnado1, 1Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Data on birth outcomes to women with rheumatoid arthritis (RA) are limited and conflicting. Some studies indicate that women with well controlled RA have…
  • Abstract Number: 1778 • ACR Convergence 2020

    Improving Teratogenic Medication Consent and Sexual Activity Screening in Adolescent and Young Females: A Pediatric Rheumatology Reproductive Health Initiative

    Veronica Mruk1, Kelly Wise2, Stacy Ardoin2, Edward Oberle2, Stephanie Lemle3, Vidya Sivaraman4, Kyla Driest2, Elise Berlan2, Cagri Yildirim-Toruner5, Jackie Maher2, Sarah Jones2 and Fatima Barbar-Smiley6, 1The Ohio State University / Nationwide Children's Hospital, Columbus, OH, 2Nationwide Children's Hospital, Columbus, OH, 3Nationwide Children's Hospital, Columubus, OH, 4Nationwide Children's Hospital, Bexley, OH, 5Nationwide Children's Hospital, Houston, TX, 6Nationwide Children's Hospital/The Ohio State University, Columbus, OH

    Background/Purpose: Adolescent and young women with rheumatic diseases are often prescribed teratogenic medications to manage their disease. Published reports indicate that the frequency of reproductive health counseling…
  • Abstract Number: 1782 • ACR Convergence 2020

    Use of a Patient-reported Survey to Document Contraceptive Use and Interest in Pregnancy to Identify Patients with Unmet Pregnancy Prevention and Planning Needs

    Megan Clowse1, Amanda Eudy2, Lisa Criscione-Schreiber3, Jayanth Doss2, Kai Sun2, Rebecca Sadun2 and Jennifer Rogers4, 1Duke University, Chapel Hill, NC, 2Duke University, Durham, NC, 3Duke University School of Medicine, Durham, NC, 4Duke, Durham, NC

    Background/Purpose: Pregnancies in women with lupus who conceive when their disease is active or they are taking a teratogen are at increased risk for pregnancy…
  • Abstract Number: 0081 • ACR Convergence 2020

    Prevalence of Systemic Autoimmune Diseases in Polycystic Ovary Syndrome

    Saika Sharmeen1, Hafsa Nomani2, Erin Taub3 and Qingping Yao3, 1Stony Brook University Renaissance School of Medicine, Dix Hills, NY, 2Stony Brook University Renaissance School of Medicine, West Babylon, NY, 3Stony Brook University Renaissance School of Medicine, Stony Brook, NY

    Background/Purpose: Polycystic ovary syndrome (PCOS) is characterized by hormonal abnormality, chronic anovulation, hyperandrogenism, and obesity. Due to the hormonal imbalance, we hypothesize that patients with…
  • Abstract Number: 1838 • ACR Convergence 2020

    Aerobic Exercise Improves Fatigue and Quality of Life in Women with Systemic Lupus Erythematosus (Preliminary Analysis)

    Marquis Chapman1, Sarthak Gupta1, Jun Chu1, Mohammad Naqi1, Zerai Manna2, Mir Ali Mazhar1, Adam Munday1, Marybeth Stockman1, Anam Ahmad1, Gayle McCrossin1, Bart Drinkard1, Lisa Chin1, Mariana Kaplan3, Randall Keyser1, Leighton Chan1 and Sarfaraz Hasni2, 1National Institutes of Health, Bethesda, MD, 2Lupus Clinical Trials Unit, NIAMS/NIH, Bethesda, MD, 3National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease of female predominance. One of the most debilitating symptoms experienced by SLE-patients is persistent…
  • Abstract Number: 0274 • ACR Convergence 2020

    The Rising Incidence of Lupus Nephritis: A Population-Based Study of Four Decades

    Mehmet Hocaoglu1, Shirley-Ann Osei-Onomah2, Jesse Dabit3, Rachel Giblon3, Thomas O'Byrne3, Fernando C. Fervenza3, Cynthia Crowson4 and Ali Duarte-Garcia3, 1University of Maryland Medical Center Midtown Campus, Baltimore, MD, 2Mayo Clinic, Rochester, 3Mayo Clinic, Rochester, MN, 4Mayo Clinic, Rochester, Minnesota, USA, Rochester, MN

    Background/Purpose: Estimating the incidence of lupus nephritis (LN) is important to understand disease burden, particularly since patients with LN have a higher morbidity and mortality…
  • Abstract Number: 0278 • ACR Convergence 2020

    Trends in Incidence of Cutaneous Lupus Erythematosus from 1976 to 2018: A Population-Based Study

    Mehmet Hocaoglu1, Mark Denis P. Davis2, Shirley-Ann Osei-Onomah3, Jesse Dabit2, Rachel Giblon2, Thomas O'Byrne2, Cynthia Crowson4 and Ali Duarte-Garcia2, 1University of Maryland Medical Center Midtown Campus, Baltimore, MD, 2Mayo Clinic, Rochester, MN, 3Mayo Clinic, Rochester, 4Mayo Clinic, Rochester, Minnesota, USA, Rochester, MN

    Background/Purpose: Cutaneous lupus erythematosus (CLE) is a heterogeneous chronic disease with potential for long lasting morbidity. Studies that provide incidence data on the entire spectrum…
  • Abstract Number: 0421 • ACR Convergence 2020

    Polymyalgia Rheumatica Is Associated with Later Menopause: An Observational Study

    Sarah Dyball1, Christopher Saleh2 and Marwan Bukhari1, 1Rheumatology Department, University Hospitals of Morecambe Bay NHS Trust, Lancaster, United Kingdom, 2Rheumatology Department, University Hospitals of Morecambe Bay NHS Trust, Manchester, United Kingdom

    Background/Purpose: Oestrogen exposure leads to an increase in peak bone mass whereas menopause is associated with rapid bone loss. Numerous studies have linked rheumatoid arthritis…
  • Abstract Number: 0437 • ACR Convergence 2020

    Integrating Reproductive Health in Systemic Lupus Erythematosus in a Tertiary Care Setting

    Jun Chu1, Sarthak Gupta1, Zerai Manna2, Michael Davis1, Yenealem Temesgen-Oyelakin1, Elaine Poncio1, Isabel Ochoa1, Laura Lewandowski3, Mariana Kaplan4, Alan Decherney1 and Sarfaraz Hasni2, 1National Institutes of Health, Bethesda, MD, 2Lupus Clinical Trials Unit, NIAMS/NIH, Bethesda, MD, 3NIAMS, NIH, Rockville, MD, 4National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD

    Background/Purpose: Systemic Lupus Erythematosus (SLE) predominantly affects women of childbearing age. Women affected by SLE have higher risk for infertility, miscarriages, and other pregnancy complications…
  • Abstract Number: 0538 • ACR Convergence 2020

    Autoimmune Disease Outcomes of Women with Breast Implants: A Population-Based Study

    Madeline Peterson1, Thomas O'Byrne1, John Davis1, Vanessa Kronzer1, Lynne Peterson1, Michael Weisman2 and Cynthia Crowson3, 1Mayo Clinic, Rochester, MN, 2Distinguished Professor of Medicine Emeritus, David Geffen School of Medicine at UCLA, LOS ANGELES, CA, 3Mayo Clinic, Rochester, Minnesota, USA, Rochester, MN

    Background/Purpose: The long-term safety of breast implants has been a debated topic; two recent studies have raised new concerns about their potential negative health effects…
  • Abstract Number: 0574 • ACR Convergence 2020

    Is Hydroxychloroquine Use a Proxy for Health Care Access? Predictors of First Dispensing Among Medicaid Beneficiaries with Incident Lupus

    Katherine Pryor1, Chang Xu1, Jamie Collins1, Karen Costenbader2 and Candace Feldman1, 1Brigham and Women's Hospital, Boston, 2Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Hydroxychloroquine/chloroquine (HCQ/CQ) is considered to be the backbone of systemic lupus erythematosus (SLE) care. Differences in receipt of HCQ/CQ may exacerbate disparities in adverse…
  • Abstract Number: 0917 • ACR Convergence 2020

    Drug-Drug Interaction Study of Nintedanib (Ofev®) and the Combination of Ethinylestradiol and Levonorgestrel (Microgynon®) in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)

    Madelon Vonk1, Mandy Avis2, Kristell Marzin3, Salome Mack3, Sven Wind3 and Martina Gahlemann4, 1Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands, Nijmegen, Netherlands, 2Boehringer Ingelheim B.V., Alkmaar, The Netherlands, Alkmaar, Netherlands, 3Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany, Biberach an der Riss, Germany, 4Boehringer Ingelheim (Schweiz) GmbH, Basel, Switzerland, Basel, Switzerland

    Background/Purpose: Nintedanib is a tyrosine kinase inhibitor that has been approved for the treatment of SSc-ILD. As nintedanib may cause fetal harm, patients taking nintedanib…
  • Abstract Number: 0938 • ACR Convergence 2020

    Low Preconceptional Complement Level Is Related with an Adverse Obstetric Outcome in a Multicentric Cohort of Pregnancy in Patients with APS and aPL Positivity

    Cecilia Nalli1, Daniele Lini2, Laura Andreoli2, Francesca Crisafulli2, Micaela Fredi2, Maria Grazia Lazzaroni2, Victoria Bitsadze3, Antonia Calligaro4, Valentina Canti5, Roberto Caporali6, Francesco Carubbi7, Cecilia Chighizola8, Paola Conigliaro9, Caterina De Carolis10, Teresa Del Ross4, Maria Favaro4, Maria Gerosa11, Annamaria Iuliano12, Jamilya Khizroeva3, Alexander Makatsariya3, Pierlugi Meroni13, Marta Mosca14, Melissa Padovan15, Roberto Perricone9, Patrizia Rovere-Querini16, Gian Domenico Sebastiani12, Chiara Tani14, Marta Tonello4, Dina Zucchi14, Franco Franceschini17 and Angela Tincani2, 1Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, Lombardia, Italy, 2Rheumatology and Clinical Immunology Unit, Spedali Civili and University of Brescia, Brescia, Lombardia, Italy, 3Department of Obstetrics and Gynecology of I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia, 4Rheumatology Unit, Department of Medicine, University Hospital of Padua, Padua, Italy, 5Immunology, Rheumatology, Allergology and Rare Disease-IRCCS San Raffaele Hospital, Laboratory of Autoimmunity and vascular inflammation San Raffaele, Milan, Italy, 6Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy, 7Department of Biotechnological and Applied Clinical Science, Rheumatology Unit, School of Medicine, University of L'Aquila, L'Aquila, Italy, 8Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy; Experimental Laboratory of Immunorheumatological Researches, Istituto Auxologico Italiano, Milan, Italy, 9Rheumatology, Allergology and Clinical Immunology, Department of "Medicina dei Sistemi", University of Rome Tor Vergata, Rome, Italy, 10Polymedical Center for Prevention of Recurrent Spontaneous Abortion, Rome, Italy, 11Division of Rheumatology, Department of Clinical Sciences and Community Health, Ospedale Gaetano Pini, University of Milan, Milan, Italy, 12Rheumatology Unit, Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy, 13Division of Rheumatology, ASST.G Pini, Department of Clinical Sciences and Community Health, University of Milan and Istituto Auxologico Italiano, Milan, Italy, 14Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 15UO e Sezione di Reumatologia, Dipartimento di Scienze Mediche, Universita' degli Studi di Ferrara, Ferrara, Italy, 16Unit of Immunology, Rheumatology, Allergy and Rare Diseases, Università Vita-Salute San Raffaele - IRCCS Ospedale San Raffaele, Milan, Italy, 17Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy

    Background/Purpose: The role of complement in the aPL related pathology has been widely studied in animal models. aPL can induce fetal loss in experimental animals but…
  • Abstract Number: 1006 • ACR Convergence 2020

    Post-menopausal Rheumatoid Arthritis Is Inversely Associated with Lifetime High Level of Estrogen Exposure in the French E3N Cohort

    Carine Salliot1, Yann Nguyen2, Amandine Gelot3, Xavier Mariette4, Marie-Christine Boutron-Ruault3 and Raphaèle Seror5, 1CHR orleans, Orleans, France, 21Department of Internal Medicine, Hôpital Beaujon, APHP Nord, Université de Paris, Clichy, Clichy, France, 3Institut Gustave Roussy, Villejuif, France, 4Paris-Sud University, Rueil-Malmaison, France, 5Rheumatology Department, Bicetre Hospital, APHP, France, Paris, France

    Background/Purpose: The involvement of female hormones in the pathogenesis of Rheumatoid Arthritis (RA) is supported by numerous observations: a female predominance, an increased incidence in…
  • Abstract Number: 1257 • ACR Convergence 2020

    Gestational Diabetes Mellitus in Pregnant Women with Systemic Lupus Erythematosus

    Sofia Gernaat1, Julia Simard2, Elisabet Svenungsson3 and Elizabeth Arkema4, 1Karolinska Institutet, Stockholm, Stockholms Lan, Sweden, 2Stanford Medicine, Stanford, CA, 3Karolinska University Hospital, Stockholm, Sweden, 4Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Increased insulin resistance is pivotal in the development of gestational diabetes mellitus (GDM). Women with SLE may be at higher risk of GDM due…
  • 1
  • 2
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.